IMS Health has announced second-quarter 2006 revenue of US$486.2 million, up 12% on a reported and constant-dollar basis, on the year earlier period. The company also announced that it is raising its 2006 earnings-per-share guidance.
Adjusted diluted earnings per share for 2006, excluding the expensing of equity-based compensation, is now expected to be in the $1.47 - $1.53 range, up from $1.45 - $1.51. 'IMS delivered another strong performance in the second quarter, the result of a focused team that continues to execute well across all regions and business lines,' according to David R. Carlucci, IMS Chairman and CEO. 'We have great momentum, and our business is stronger than ever.'
On an adjusted basis, excluding the expensing of equity-based compensation, net income rose 2% to $79.3m for the 2006 second quarter. Including the expensing of equity-based compensation, adjusted net income for the second quarter of 2006 was $70.9m, down 9%. Operating income in the second quarter of 2006 was $106.3m on an SEC-reported basis, up 3%, compared with $103.3m in the year-earlier period.
For the first half of 2006, revenues were US$932.4 million, up 10% (12% constant dollar), compared with revenue of US$844.3 million for the first half of 2005. Net income on an SEC-reported basis for the first half of 2006 was US$180.8 million, compared with US$123.5 million in the year-earlier period.
The company is online at www.imshealth.com
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online